Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2000
04/13/2000CA2346452A1 Methods and adjuvants for stimulating mucosal immunity
04/13/2000CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands
04/13/2000CA2346443A1 Prostaglandin receptor ligands
04/13/2000CA2346040A1 New bis-benzimidazoles
04/13/2000CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
04/13/2000CA2345997A1 Benzamide derivatives as thrombin inhibitors
04/13/2000CA2345881A1 Bone marrow-derived serum proteins
04/13/2000CA2345789A1 New crystal modification iii of torasemide
04/13/2000CA2345577A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation
04/13/2000CA2345209A1 Antisense modulation of integrin .alpha.4 expression
04/13/2000CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
04/12/2000EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof
04/12/2000EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists
04/12/2000EP0991666A1 Alpha 1-antitrypsin preparation and method for the production thereof
04/12/2000EP0991665A1 Peptides and compounds that bind to the il-5 receptor
04/12/2000EP0991659A1 Peptides and compounds that bind to the il-5 receptor
04/12/2000EP0991653A1 Novel compounds
04/12/2000EP0991650A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
04/12/2000EP0991630A1 Crystalline roxifiban
04/12/2000EP0991411A1 Treatment for pulmonary fibrosis
04/12/2000EP0991406A1 Il-8 receptor antagonists
04/12/2000EP0794951B1 Processes and intermediates for preparing cis (+) 3-[4,6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline
04/12/2000CN1250450A Novel pyrimidine derivative
04/12/2000CN1249945A Throat smoothing candy made of sterculia scaphigera
04/11/2000US6048897 Lipoxin compounds and their use in treating cell proliferative disorders
04/11/2000US6048889 Proline derivatives
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048879 Dietetics
04/11/2000US6048844 Treatment of conditions and disease
04/11/2000CA2182086C Use of mometasone furoate for treating airway passage and lung diseases
04/08/2000CA2285120A1 Heterocycles
04/06/2000WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018768A1 Novel salts of pyridopyrazine compound and crystals thereof
04/06/2000WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders
04/06/2000WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors
04/06/2000WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018429A2 Vaccine based on attenuated $i(haemophilus somnus)
04/06/2000WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
04/06/2000WO2000018404A1 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000WO2000018388A2 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000WO2000018386A2 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000WO2000018381A1 Use of epinastine as antitussivum
04/06/2000WO2000018230A1 Combination of bisphosphonate and tetracycline
04/06/2000WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
04/06/2000WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
04/06/2000DE19845358A1 Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe Excessive dosage forms with controlled release
04/06/2000CA2774207A1 Antibiotic compositions for treatment of the eye
04/06/2000CA2659064A1 Antibiotic compositions for treatment of the ear and nose
04/06/2000CA2345362A1 Novel salts of pyridopyrazine compound and crystals thereof
04/06/2000CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000CA2344050A1 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000CA2343934A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000CA2343716A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
04/06/2000CA2343098A1 Combination of bisphosphonate and tetracycline
04/06/2000CA2342603A1 Antibiotic compositions for treatment of the eye, ear and nose
04/06/2000CA2340454A1 Benzamide derivatives and their use as cytokine derivatives
04/06/2000CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/05/2000EP0990437A1 Aerosol compositions
04/05/2000EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/05/2000EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
04/05/2000EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy
04/05/2000EP0989849A2 Therapeutic nanospheres
04/05/2000CN1249749A Phthalazinones
04/05/2000CN1249748A Small molecules useful in treatment of inflamatory disease
04/05/2000CN1249744A Nitric oxide synthase inhibitors
04/05/2000CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy
04/05/2000CN1249183A Medicine for treating chronic trachitis and bronchitis and its preparing process
04/05/2000CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof
04/04/2000US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors
04/04/2000US6046233 Agent for treating cor pulmonale
04/04/2000US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
04/04/2000US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative
04/04/2000US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae
04/04/2000US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases
04/04/2000US6045792 Human proteins kinases
04/04/2000US6045778 Stabilized medicinal aerosol solution formulations
04/04/2000CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins
04/04/2000CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
03/2000
03/30/2000WO2000017644A1 Ndp
03/30/2000WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
03/30/2000WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
03/30/2000WO2000017392A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
1 ... 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 ... 878